Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Jazz Pharmaceuticals plc
About JAZZ
Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.
Find out what a historical investment in Jazz Pharmaceuticals plc would be worth today using our JAZZ stock calculator.
Market Capitalisation
$14.90B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
835.31K
High today
$242.18
Low today
$235.99
Open price
$239.77
52-week high
$238.55
52-week low
$105.00
Ready to start your investing journey with Stake?
Open an accountHow do I buy JAZZ shares in Australia?
Buying JAZZ shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Jazz Pharmaceuticals plc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in JAZZ
What is the ticker symbol of Jazz Pharmaceuticals plc?
The ticker symbol for Jazz Pharmaceuticals plc is JAZZ.
How much is one share of JAZZ?
One share of JAZZ is valued at $239.08 as of 20 May 2026.
What is the market capitalisation of Jazz Pharmaceuticals plc JAZZ?
As of 20 May 2026 Jazz Pharmaceuticals plc has a market cap of $14.90B.
What is the P/E ratio of JAZZ?
The Price to Earnings ratio of JAZZ is 2232.93.
What is the Earnings Per Share of JAZZ?
The Earnings Per Share of JAZZ is $0.11.
What is the 52-week high for Jazz Pharmaceuticals plc stock?
The Jazz Pharmaceuticals plc 52-week high stock price is $238.55.
What is the 52-week low for Jazz Pharmaceuticals plc stock?
The Jazz Pharmaceuticals plc 52-week low stock price is $105.00.
Can I buy JAZZ shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy JAZZ shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in JAZZ on Stake
- Buy JAZZ from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of JAZZ from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
JAZZ related stocks